OKT_3在肾移植中的应用被引量：1

暂未订购

导出

摘要肾移植术后应用 OKT3 5 mg/ d(iv) ,连用 7～12 d,结果表明 OKT3

作者宋明山秦元喜宋伟贞赵永伟郝树铭梅如冰

机构地区山东省泰安市中心医院泌尿外科山东省莱芜市高庄医院泌尿外科

出处《西北药学杂志》 CAS 2001年第6期271-272,共2页 Northwest Pharmaceutical Journal

关键词肾移植 OKT3 排斥反应临床应用免疫抑制剂

参考文献6

1[1]Rostating L, Chabannier MH, Modesto A, et al . Predicting factors of long-term results of OKT3 therapy for steroid resista nt acute rejection following cadaveric renal transplantation. Am J Nephrol, 1999,19(6):634
2[2]Tesi RJ, Eikhammase EA, Henry ML, et al. OKT 3 for primary therapy of the first rejection episode in kidney. Transplantat ion, 1993,55:1023
3[3]Norman DJ, Kahana L, Stuart FP, et al. A ran domized clinical trial of induction therapy with OKT3 in kidney transplantatio n. Transplantation, 1993,55(1):44
4[4]Parlevliet KJ, Bemelman FJ, Yong SL, et al. Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients. Transp Int, 1995,8(2):141
5[5]Opelz G. Efficacy of rejection prophylaxis w ith OKT3 in renal transplantation. Collaborative Transplant Study. Transplan tation, 1995,60(11):1220
6[6]Thistlethwaite JR, Stuart JK, Mayes JT, et a l. Complications and monitoring of OKT3 therapy. AM J Kidney Dis, 1998,11( 2):112

1Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: theBanff working classification of kidney transplant pathology [J]. Kidney Int, 1993,44(2) :411.
2Rostating L, Chabannier MH, Modesto A, et al. Predicting factors of longerm results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation[J]. Am J Nephrol, 1999,19(6) :634.
3Norman DJ, Kahana L, Stuart FP, et al. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation[J]. Transplantation, 1993,55(1) :44.
4Thistlethwaite JR, Stuart JK, Mayes JT, et al. Complications and monitoring of OKT3 therapy[J]. Am J Kidney Dis, 1998,11(1): 112.
5黄先恩,李留洋,范礼佩,郭颖,李民,赵明,夏穗生.氨基酸残基配型在致敏受者肾移植中的应用[J].肾脏病与透析肾移植杂志,2004,13(1):40-43. 被引量：1

1董鸣,孙晓峻.OKT_3在肾移植中的使用[J].中国新药杂志,2000,9(2):84-86. 被引量：1
2叶桂荣,刘淑粉,宣蓓.OKT_3致神经及精神症状1例[J].山西护理杂志,1996,10(6):268-269.
3孔娟.1例应用OKT3出现急性肺水肿患者的抢救与护理[J].美国中华临床医学杂志,2002,4(4):318-318.
4徐健,于立新,马俊杰,付绍杰.移植肾难治性排斥反应对OKT3治疗的延迟性反应[J].中华泌尿外科杂志,1996,17(11):695-695. 被引量：1
5翁国斌,祁洪刚,唐莉,姜继光,张曙伟,姚许平,陈知水.小剂量OKT3联合他克莫司治疗肾移植术后急性排斥反应的临床观察[J].现代实用医学,2005,17(3):154-155.
6徐健,于立新,马俊杰,白喜文.CsA顺序用药对移植肾早期功能的影响[J].中华泌尿外科杂志,1996,17(6):341-344. 被引量：6
7王海坤,张明,钟戈宁,李智刚.FK506与CsA在肾移植术后抗排斥的临床应用[J].现代泌尿外科杂志,2002,7(2):85-87. 被引量：1
8张海燕,陈统清,孔耀中,黄英伟.赛尼哌两剂疗法预防移植肾急性排斥反应的临床研究[J].中国临床保健杂志,2004,7(5):351-353. 被引量：4
9于立新,杜传福,徐健,付绍杰,马俊杰,邓文锋,叶桂荣,王亦斌,姚冰,刘小友.他克莫司治疗肾移植术后耐激素性排斥反应的临床观察[J].中华器官移植杂志,2001,22(6):361-363. 被引量：2
10郭宏波,张玉海.麦考酚酸酯在肾移植中的应用[J].友谊医学,2001,24(1):15-16.

西北药学杂志

2001年第6期

内容加载中请稍等...